1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid TumorsHR+, HER2-, Advanced Breast Cancer; HR+/HER2- Breast CancerRecruitingPhase 1 / Phase 22026-08-10NCT06998407